Physician profile
Michael P Castro
NPI 1306834338
$10,205.79
in general payments reported to CMS, 2019-2025
70 companies · $2,913 in 2025
The $2,913 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,024 · 2020: $819 · 2021: $1,424 · 2022: $1,416 · 2023: $772 · 2024: $838 · 2025: $2,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,627 · Travel and Lodging: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,627.22 |
| Travel and Lodging | $895.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,064.50 | 2021-2025 | |
| Intuitive Surgical, INC. | $895.38 | 2025 | |
| Pfizer INC. | $647.41 | 2019-2025 | |
| Genentech USA, INC. | $526.58 | 2019-2025 | Polivy, Itovebi, Venclexta |
| Janssen Biotech, INC. | $521.22 | 2019-2025 | Rybrevant, Erleada, Balversa |
| Novartis Pharmaceuticals Corporation | $451.54 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $353.44 | 2019-2025 | Enhertu, Lynparza, Calquence |
| Foundation Medicine, INC. | $329.81 | 2020-2021 | |
| Incyte Corporation | $277.33 | 2021-2025 | Jakafi |
| Amgen INC. | $265.33 | 2019-2022 | |
| Pharmacyclics LLC, An Abbvie Company | $259.43 | 2019-2023 | Epkinly, Imbruvica |
| Astellas Pharma US INC | $230.27 | 2019-2025 | Padcev, Vyloy, Xospata |
| Daiichi Sankyo INC. | $228.53 | 2022-2025 | Enhertu |
| Springworks Therapeutics, INC. | $221.57 | 2024-2025 | Gomekli, Ogsiveo |
| Abbvie INC. | $219.66 | 2024-2025 |
Show all 70 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.